353 related articles for article (PubMed ID: 19519313)
1. Towards retinoid therapy for Alzheimer's disease.
Shudo K; Fukasawa H; Nakagomi M; Yamagata N
Curr Alzheimer Res; 2009 Jun; 6(3):302-11. PubMed ID: 19519313
[TBL] [Abstract][Full Text] [Related]
2. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
3. Retinoids as potential targets for Alzheimer's disease.
Sodhi RK; Singh N
Pharmacol Biochem Behav; 2014 May; 120():117-23. PubMed ID: 24582848
[TBL] [Abstract][Full Text] [Related]
4. Are retinoids a promise for Alzheimer's disease management?
Carratù MR; Marasco C; Signorile A; Scuderi C; Steardo L
Curr Med Chem; 2012; 19(36):6119-25. PubMed ID: 23092137
[TBL] [Abstract][Full Text] [Related]
5. Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.
Chakrabarti M; McDonald AJ; Will Reed J; Moss MA; Das BC; Ray SK
J Alzheimers Dis; 2016; 50(2):335-52. PubMed ID: 26682679
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic insights elaborating the potential of retinoids in Alzheimer's disease.
Behl T; Kaur D; Sehgal A; Singla RK; Makeen HA; Albratty M; Alhazmi HA; Meraya AM; Bungau S
Front Pharmacol; 2022; 13():976799. PubMed ID: 36091826
[TBL] [Abstract][Full Text] [Related]
7. [Retinoid therapy for autoimmune diseases].
Fukasawa H; Kagechika H; Shudo K
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):114-26. PubMed ID: 16819260
[TBL] [Abstract][Full Text] [Related]
8. Tamibarotene: a candidate retinoid drug for Alzheimer's disease.
Fukasawa H; Nakagomi M; Yamagata N; Katsuki H; Kawahara K; Kitaoka K; Miki T; Shudo K
Biol Pharm Bull; 2012; 35(8):1206-12. PubMed ID: 22863914
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
10. Retinoid, retinoic acid receptor beta and breast cancer.
Yang Q; Sakurai T; Kakudo K
Breast Cancer Res Treat; 2002 Nov; 76(2):167-73. PubMed ID: 12452454
[TBL] [Abstract][Full Text] [Related]
11. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
Uray IP; Dmitrovsky E; Brown PH
Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
[TBL] [Abstract][Full Text] [Related]
12. Diverse actions of retinoid receptors in cancer prevention and treatment.
Mongan NP; Gudas LJ
Differentiation; 2007 Nov; 75(9):853-70. PubMed ID: 17634071
[TBL] [Abstract][Full Text] [Related]
13. Distinct functions of retinoic acid receptor beta isoforms: implications for targeted therapy.
Swift CB; Hays JL; Petty WJ
Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):47-50. PubMed ID: 18393922
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain.
Corcoran JP; So PL; Maden M
Eur J Neurosci; 2004 Aug; 20(4):896-902. PubMed ID: 15305858
[TBL] [Abstract][Full Text] [Related]
15. Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease.
Das BC; Dasgupta S; Ray SK
Neural Regen Res; 2019 Nov; 14(11):1880-1892. PubMed ID: 31290437
[TBL] [Abstract][Full Text] [Related]
16. International Union of Pharmacology. LX. Retinoic acid receptors.
Germain P; Chambon P; Eichele G; Evans RM; Lazar MA; Leid M; De Lera AR; Lotan R; Mangelsdorf DJ; Gronemeyer H
Pharmacol Rev; 2006 Dec; 58(4):712-25. PubMed ID: 17132850
[TBL] [Abstract][Full Text] [Related]
17. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors.
Yang Y; Minucci S; Ozato K; Heyman RA; Ashwell JD
J Biol Chem; 1995 Aug; 270(31):18672-7. PubMed ID: 7629199
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic perspectives of drugs targeting Toll-like receptors based on immune physiopathology theory of Alzheimer's disease.
Schneider AR; Sari Y
CNS Neurol Disord Drug Targets; 2014; 13(5):909-20. PubMed ID: 25012616
[TBL] [Abstract][Full Text] [Related]
19. Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease.
Kulshreshtha A; Piplani P
Neurol Sci; 2016 Sep; 37(9):1403-35. PubMed ID: 27250365
[TBL] [Abstract][Full Text] [Related]
20. Retinoids for treatment of Alzheimer's disease.
Lerner AJ; Gustaw-Rothenberg K; Smyth S; Casadesus G
Biofactors; 2012; 38(2):84-9. PubMed ID: 22419567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
